endogene.bio
TechBio company generating biological data from menstrual blood to study uterine biology.
At a glance
- Primary health focus
- Endometriosis
About
endogene.bio is a TechBio company generating high-resolution biological data from menstrual blood to create a non-invasive window into uterine biology for patient stratification, biomarker development and therapeutic discovery. It is connected to the Swiss ecosystem through the DayOne Healthtech Innovation Accelerator 2026 in Basel.
Need addressed
Uterine diseases such as endometriosis remain difficult to study and stratify because disease-relevant biology is not easily accessible without invasive procedures.
Women’s health focus
Primary health area
EndometriosisIts platform uses menstrual blood-derived molecular data to study uterine disease biology and support patient stratification and therapeutic discovery.
Additional health area
FertilityAdditional health area
Menstrual Health